Updated Jul 16, 2026
Polsky Bruce has filed 1 SEC Form 4 filing across 1 company in the last 90 days.

Bruce Polsky is identified in SEC filings as an insider associated with Atea Pharmaceuticals, Inc. as of the 2026-06-23 filing date. The exact title or role is not specified in the provided context; he is presumably an executive or director given the insider-disclosure context. Public records from the filings suggest involvement in corporate governance and investor communications for Atea, but detailed biographical information is not contained in the cited documents. To confirm his current role and background, one would need to review the specific SEC filing materials (e.g., Form 4, Form 13D, or annual/quarterly reports) for Atea Pharmaceuticals.
| Role | Insider |
|---|---|
| Notability | 40/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-23 | AVIR | Atea Pharmaceuticals, Inc. | M — Option exercise | 29.6K | $0.00 |
Bruce Polsky is identified in SEC filings as an insider associated with Atea Pharmaceuticals, Inc. as of the 2026-06-23 filing date. The exact title or role is not specified in the provided context; he is presumably an executive or director given the insider-disclosure context. Public records from the filings suggest involvement in corporate governance and investor communicatio…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Polsky Bruce profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.